December 2023 – content

 Life Sciences

Automata raises further funds for international expansion

Optibrium adds capabilities for structure-based drug design

SomaLogic and Standard Biotools combine in pursuit of profitability

Proteintech expands in the US and China

 

General Laboratory

Thomas Scientific expands with three more acquisitions

Purchase expands Altmann Analytik’s domestic market reach              

Shimadzu acquires software developer Biomaneo

STARLIMS makes first acquisition

Park Systems builds HQs

Azurlight expands Toptica’s reach into French market

Ametek to acquire medical device specialist              

Metrohm and Agilent expand reseller partnerships

Hamamatsu opens microfocus X-ray source facility

 

Process & hand-held instrumentation

Repligen buys mixing company and single-use expert

Gamma radiation specialist joins OSI System’s Security division

Polysciences creates new bioprocessing reagent brand

 

Feature

IN Leaderboard 2023 (Top 40): Spin-offs begin to affect listing ranks

 

Financials

Sartorius suffers the expected drop of pandemic sales

SomaLogic performs in line with expectations

Mesa Labs hits Covid cliff edge              

Revvity’s LS grows organically, though Dx hits pandemic cliff-edge

Bio-Rad lowers growth guidance on biopharma softness

Sales and profitability improve at Standard Biotools

Markes sees slow growth in challenging 2022

HEL increases workforce in anticipation of future growth

Toptica continues growth momentum

Buoyed by strong first half Spectris ups full-year forecast

Trajan delivers 12th consecutive year of growth

Stanhope-Seta sees sales dip

Horiba Scientific plagued by low profitability              

Softer laboratory sales overshadow Mettler-Toledo’s half-year results

Astrea acquisition boosts Biotage

Aerospace sales recover at Ametek EIG

Repligen’s filtration sales hit by waning demand

X-ray modules strong at Comet

Smiths Detection returns “firmly to growth”

Leidos notes partial recovery of security products portfolio

Post-Covid recovery at Hach Lange in line with Danaher’s EAS division

Strong growth at PreSens in second pandemic year

 

Appointments